The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cholera Vaccines Market Research Report 2024
Synopsis
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.
The global Cholera Vaccines market was valued at US$ 83 million in 2023 and is anticipated to reach US$ 153.8 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cholera Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholera Vaccines.
Report Scope
The Cholera Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cholera Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholera Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Segment by Type
Dukoral
Shanchol
Vaxchora
Others
Segment by Application
Oral
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cholera Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.
The global Cholera Vaccines market was valued at US$ 83 million in 2023 and is anticipated to reach US$ 153.8 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cholera Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholera Vaccines.
Report Scope
The Cholera Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cholera Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholera Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Segment by Type
Dukoral
Shanchol
Vaxchora
Others
Segment by Application
Oral
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cholera Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cholera Vaccines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dukoral
1.2.3 Shanchol
1.2.4 Vaxchora
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cholera Vaccines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oral
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cholera Vaccines Market Perspective (2019-2030)
2.2 Cholera Vaccines Growth Trends by Region
2.2.1 Global Cholera Vaccines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cholera Vaccines Historic Market Size by Region (2019-2024)
2.2.3 Cholera Vaccines Forecasted Market Size by Region (2025-2030)
2.3 Cholera Vaccines Market Dynamics
2.3.1 Cholera Vaccines Industry Trends
2.3.2 Cholera Vaccines Market Drivers
2.3.3 Cholera Vaccines Market Challenges
2.3.4 Cholera Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cholera Vaccines Players by Revenue
3.1.1 Global Top Cholera Vaccines Players by Revenue (2019-2024)
3.1.2 Global Cholera Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cholera Vaccines Revenue
3.4 Global Cholera Vaccines Market Concentration Ratio
3.4.1 Global Cholera Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cholera Vaccines Revenue in 2023
3.5 Cholera Vaccines Key Players Head office and Area Served
3.6 Key Players Cholera Vaccines Product Solution and Service
3.7 Date of Enter into Cholera Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cholera Vaccines Breakdown Data by Type
4.1 Global Cholera Vaccines Historic Market Size by Type (2019-2024)
4.2 Global Cholera Vaccines Forecasted Market Size by Type (2025-2030)
5 Cholera Vaccines Breakdown Data by Application
5.1 Global Cholera Vaccines Historic Market Size by Application (2019-2024)
5.2 Global Cholera Vaccines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cholera Vaccines Market Size (2019-2030)
6.2 North America Cholera Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cholera Vaccines Market Size by Country (2019-2024)
6.4 North America Cholera Vaccines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cholera Vaccines Market Size (2019-2030)
7.2 Europe Cholera Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cholera Vaccines Market Size by Country (2019-2024)
7.4 Europe Cholera Vaccines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cholera Vaccines Market Size (2019-2030)
8.2 Asia-Pacific Cholera Vaccines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cholera Vaccines Market Size by Region (2019-2024)
8.4 Asia-Pacific Cholera Vaccines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cholera Vaccines Market Size (2019-2030)
9.2 Latin America Cholera Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cholera Vaccines Market Size by Country (2019-2024)
9.4 Latin America Cholera Vaccines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cholera Vaccines Market Size (2019-2030)
10.2 Middle East & Africa Cholera Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cholera Vaccines Market Size by Country (2019-2024)
10.4 Middle East & Africa Cholera Vaccines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shantha Biotechnics Private Limited
11.1.1 Shantha Biotechnics Private Limited Company Detail
11.1.2 Shantha Biotechnics Private Limited Business Overview
11.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Introduction
11.1.4 Shantha Biotechnics Private Limited Revenue in Cholera Vaccines Business (2019-2024)
11.1.5 Shantha Biotechnics Private Limited Recent Development
11.2 PaxVax, Inc.
11.2.1 PaxVax, Inc. Company Detail
11.2.2 PaxVax, Inc. Business Overview
11.2.3 PaxVax, Inc. Cholera Vaccines Introduction
11.2.4 PaxVax, Inc. Revenue in Cholera Vaccines Business (2019-2024)
11.2.5 PaxVax, Inc. Recent Development
11.3 Valneva SE
11.3.1 Valneva SE Company Detail
11.3.2 Valneva SE Business Overview
11.3.3 Valneva SE Cholera Vaccines Introduction
11.3.4 Valneva SE Revenue in Cholera Vaccines Business (2019-2024)
11.3.5 Valneva SE Recent Development
11.4 Merck and Co., Inc.
11.4.1 Merck and Co., Inc. Company Detail
11.4.2 Merck and Co., Inc. Business Overview
11.4.3 Merck and Co., Inc. Cholera Vaccines Introduction
11.4.4 Merck and Co., Inc. Revenue in Cholera Vaccines Business (2019-2024)
11.4.5 Merck and Co., Inc. Recent Development
11.5 GlaxoSmithKline plc (GSK)
11.5.1 GlaxoSmithKline plc (GSK) Company Detail
11.5.2 GlaxoSmithKline plc (GSK) Business Overview
11.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Introduction
11.5.4 GlaxoSmithKline plc (GSK) Revenue in Cholera Vaccines Business (2019-2024)
11.5.5 GlaxoSmithKline plc (GSK) Recent Development
11.6 Astellas Pharma, Inc.
11.6.1 Astellas Pharma, Inc. Company Detail
11.6.2 Astellas Pharma, Inc. Business Overview
11.6.3 Astellas Pharma, Inc. Cholera Vaccines Introduction
11.6.4 Astellas Pharma, Inc. Revenue in Cholera Vaccines Business (2019-2024)
11.6.5 Astellas Pharma, Inc. Recent Development
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Detail
11.7.2 Pfizer, Inc. Business Overview
11.7.3 Pfizer, Inc. Cholera Vaccines Introduction
11.7.4 Pfizer, Inc. Revenue in Cholera Vaccines Business (2019-2024)
11.7.5 Pfizer, Inc. Recent Development
11.8 Emergent BioSolutions, Inc.
11.8.1 Emergent BioSolutions, Inc. Company Detail
11.8.2 Emergent BioSolutions, Inc. Business Overview
11.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Introduction
11.8.4 Emergent BioSolutions, Inc. Revenue in Cholera Vaccines Business (2019-2024)
11.8.5 Emergent BioSolutions, Inc. Recent Development
11.9 Mitsubishi Tanabe Pharma Corporation
11.9.1 Mitsubishi Tanabe Pharma Corporation Company Detail
11.9.2 Mitsubishi Tanabe Pharma Corporation Business Overview
11.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Introduction
11.9.4 Mitsubishi Tanabe Pharma Corporation Revenue in Cholera Vaccines Business (2019-2024)
11.9.5 Mitsubishi Tanabe Pharma Corporation Recent Development
11.10 Takeda Pharmaceutical Co., Ltd.
11.10.1 Takeda Pharmaceutical Co., Ltd. Company Detail
11.10.2 Takeda Pharmaceutical Co., Ltd. Business Overview
11.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Introduction
11.10.4 Takeda Pharmaceutical Co., Ltd. Revenue in Cholera Vaccines Business (2019-2024)
11.10.5 Takeda Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
